한빛사논문 | BRIC

구태영 님의 논문 목록

경희대학교 약학대학

[Letter] CRISPR base editing-mediated correction of a tau mutation rescues cognitive decline in a mouse model of tauopathy
- Transl. Neurodegener., Apr 12 2024, 13 (1) 21 | https://doi.org/10.1186/s40035-024-00415-y
- 2024-04
- 의약학
- 한빛사논문
CRISPR-mediated ablation of TP53 and EGFR mutations enhances gefitinib sensitivity and anti-tumor efficacy in a mouse model of lung cancer
- Mol. Ther., Available online 25 July 2024 | https://doi.org/10.1016/j.ymthe.2024.07.017
- 2024-07
- 의약학
- 한빛사논문
CRISPR technologies for the treatment of Duchenne muscular dystrophy
- Mol. Ther., 2021 Nov 3;29(11):3179-3191 | https://doi.org/10.1016/j.ymthe.2021.04.002
- 2021-11
- 생명과학
- 한빛사논문
Expanded targeting scope of LbCas12a variants allows editing of multiple oncogenic mutations
- Mol. Ther.-Nucl. Acids, Volume 30, 13 Dec 2022, Pages 131-142 | https://doi.org/10.1016/j.omtn.2022.09.005
- 2022-12
- 생명과학
- 한빛사논문
CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
- Nat. Commun., Published: 10 May 2018, 9, Article number: 1855 | doi:10.1038/s41467-018-04175-y
- 2018-05
- 생명과학
- 한빛사논문
Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy
- Nat. Biotechnol., 36, pages 536-539 (2018). Published online 27 April 2018 | doi:10.1038/nbt.4148
- 2018-04
- 생명과학
- 한빛사논문, 상위피인용논문
CRISPR RNAs trigger innate immune responses in human cells
- Genome Res., Published in Advance February 22, 2018 | doi: 10.1101/gr.231936.117
- 2018-02
- 생명과학
- 한빛사논문, 상위피인용논문
Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression
- Nucleic Acids Res., 27 July 2017, 45 (13): 7897-7908 | DOI: https://doi.org/10.1093/nar/gkx490
- 2017-07
- 생명과학
- 한빛사논문
In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
- Nat. Commun., Published online:21 February 2017, 8, Article number: 14500 | doi:10.1038/ncomms14500
- 2017-02
- 생명과학
- 한빛사논문, 상위피인용논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기